{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:42:23Z","timestamp":1772131343707,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T00:00:00Z","timestamp":1420848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10689-015-9778-z","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T12:41:55Z","timestamp":1420807315000},"page":"241-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer"],"prefix":"10.1007","volume":"14","author":[{"given":"Iikki","family":"Donner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuula","family":"Kiviluoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Ristim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri A.","family":"Aaltonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Vahteristo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,10]]},"reference":[{"key":"9778_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al. (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon. http:\/\/globocan.iarc.fr . Accessed on 13 Dec 2013"},{"key":"9778_CR2","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/1097-0142(19901101)66:9<2047::AID-CNCR2820660934>3.0.CO;2-G","volume":"66","author":"G Zanghieri","year":"1990","unstructured":"Zanghieri G, Gregorio CD, Sacchetti C, Fante R, Sassatelli R et al (1990) Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66:2047\u20132051","journal-title":"Cancer"},{"key":"9778_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I","volume":"70","author":"C Vecchia La","year":"1992","unstructured":"La Vecchia C, Negri E, Franceschi S, Gentile A (1992) Family history and the risk of stomach and colorectal cancer. Cancer 70:50\u201355","journal-title":"Cancer"},{"key":"9778_CR4","first-page":"15","volume":"3","author":"D Palli","year":"1994","unstructured":"Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A et al (1994) Family history and risk of gastric cancer in Italy. Cancer Epidemiol Biomarkers Prev 3:15\u201318","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9778_CR5","first-page":"873","volume":"36","author":"C Caldas","year":"1999","unstructured":"Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL et al (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36:873\u2013880","journal-title":"J Med Genet"},{"issue":"6","key":"9778_CR6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/carcin\/20.6.1127","volume":"20","author":"K Shinmura","year":"1999","unstructured":"Shinmura K, Kohno T, Takahashi M, Sasaki A, Ochiai A et al (1999) Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 20(6):1127\u20131131","journal-title":"Carcinogenesis"},{"key":"9778_CR7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/gutjnl-2011-300348","volume":"61","author":"DL Worthley","year":"2012","unstructured":"Worthley DL, Phillips KD, Wayte N, Schrader KA, Healey S et al (2012) Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut 61:774\u2013779","journal-title":"Gut"},{"key":"9778_CR8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1053\/gast.1996.v110.pm8612988","volume":"110","author":"HFA Vasen","year":"1996","unstructured":"Vasen HFA, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020\u20131027","journal-title":"Gastroenterology"},{"key":"9778_CR9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<551::AID-IJC13>3.0.CO;2-9","volume":"74","author":"M Aarnio","year":"1997","unstructured":"Aarnio M, Salovaara R, Aaltonen LA, Mecklin JP, J\u00e4rvinen HJ (1997) Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 74:551\u2013555","journal-title":"Int J Cancer"},{"key":"9778_CR10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/90.14.1039","volume":"90","author":"NM Lindor","year":"1998","unstructured":"Lindor NM, Greene MH (1998) The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 90:1039\u20131071","journal-title":"J Natl Cancer Inst"},{"key":"9778_CR11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/jmg.32.12.942","volume":"32","author":"JM Varley","year":"1995","unstructured":"Varley JM, McGown G, Thorncroft M, Tricker KJ, Teare MD et al (1995) An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation of TP53. J Med Genet 32:942\u2013945","journal-title":"J Med Genet"},{"key":"9778_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P (1965) The two histological main types of gastric carcinoma, an attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64:31\u201349","journal-title":"Acta Pathol Microbiol Scand"},{"key":"9778_CR13","volume-title":"WHO classification of tumours of the digestive system","year":"2010","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) (2010) WHO classification of tumours of the digestive system, 4th edn. IARC, Lyon","edition":"4"},{"key":"9778_CR14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1054\/bjoc.2000.1602","volume":"84","author":"S Kaneko","year":"2001","unstructured":"Kaneko S, Yoshimura T (2001) Time trend analysis of gastric cancer incidence in japan by histological types, 1975\u20131989. Br J Cancer 84:400","journal-title":"Br J Cancer"},{"key":"9778_CR15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/jnci\/83.9.640","volume":"83","author":"J Parsonnet","year":"1991","unstructured":"Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J et al (1991) Helicobacter pylori infection in intestinal-and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 83:640\u2013643","journal-title":"J Natl Cancer Inst"},{"key":"9778_CR16","first-page":"459","volume":"79","author":"JC Machado","year":"1999","unstructured":"Machado JC, Soares P, Carneiro F, Rocha A, Beck S et al (1999) E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79:459\u2013465","journal-title":"Lab Invest"},{"key":"9778_CR17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jmg.2009.074237","volume":"47","author":"RC Fitzgerald","year":"2010","unstructured":"Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P et al (2010) Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 47:436\u2013444","journal-title":"J Med Genet"},{"key":"9778_CR18","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","volume":"121","author":"PD Pharoah","year":"2001","unstructured":"Pharoah PD, Guilford P, Caldas C (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121:1348\u20131353","journal-title":"Gastroenterology"},{"issue":"4","key":"9778_CR19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/path.4152","volume":"229","author":"IJ Majewski","year":"2013","unstructured":"Majewski IJ, Kluijt I, Cats A, Scerri TS, de Jong D et al (2013) An \u03b1-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. J Pathol 229(4):621\u2013629. doi: 10.1002\/path.4152","journal-title":"J Pathol"},{"key":"9778_CR20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K et al (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297\u20131303","journal-title":"Genome Res"},{"key":"9778_CR21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajhg.2011.03.004","volume":"88","author":"A Gonz\u00e1lez-P\u00e9rez","year":"2011","unstructured":"Gonz\u00e1lez-P\u00e9rez A, L\u00f3pez-Bigas N (2011) Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 88:440\u2013449","journal-title":"Am J Hum Genet"},{"key":"9778_CR22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248\u2013249","journal-title":"Nat Methods"},{"key":"9778_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2164-11-293","volume":"11","author":"Y Chen","year":"2010","unstructured":"Chen Y, Cunningham F, Rios D, McLaren WM, Smith J et al (2010) Ensembl variation resources. BMC Genom 11:293","journal-title":"BMC Genom"},{"key":"9778_CR24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073\u20131081","journal-title":"Nat Protoc"},{"key":"9778_CR25","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39:e118","journal-title":"Nucleic Acids Res"},{"key":"9778_CR26","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","volume":"19","author":"F Frasca","year":"1999","unstructured":"Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R et al (1999) Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278\u20133288","journal-title":"Mol Cell Biol"},{"key":"9778_CR27","doi-asserted-by":"crossref","first-page":"39684","DOI":"10.1074\/jbc.M202766200","volume":"277","author":"G Pandini","year":"2002","unstructured":"Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R et al (2002) Insulin\/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277:39684\u201339695","journal-title":"J Biol Chem"},{"key":"9778_CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0021-9258(17)42304-0","volume":"269","author":"DJ Horn Van","year":"1994","unstructured":"Van Horn DJ, Myers MG Jr, Backer JM (1994) Direct activation of the phosphatidylinositol 3\u2032-kinase by the insulin receptor. J Biol Chem 269:29\u201332","journal-title":"J Biol Chem"},{"key":"9778_CR29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M (2008) Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer 8:915\u2013928","journal-title":"Nat Rev Cancer"},{"key":"9778_CR30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1055\/s-2004-814157","volume":"35","author":"A Denley","year":"2003","unstructured":"Denley A, Wallace JC, Cosgrove LJ, Forbes BE (2003) The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. Horm Metab Res 35:778\u2013785","journal-title":"Horm Metab Res"},{"key":"9778_CR31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ygyno.2012.03.012","volume":"125","author":"W Yingmei","year":"2012","unstructured":"Yingmei W, Shaofang H, Wenyan T, Zhang L, Zhao J et al (2012) Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase\/Akt dependent. Gynecol Oncol 125:734\u2013741","journal-title":"Gynecol Oncol"},{"issue":"11","key":"9778_CR32","doi-asserted-by":"crossref","first-page":"e81579","DOI":"10.1371\/journal.pone.0081579","volume":"8","author":"JCM de-Freitas-Junior","year":"2013","unstructured":"de-Freitas-Junior JCM, Carvalho S, Dias AM, Oliveira P, Cabral J et al (2013) Insulin\/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNac N-glycans modulation. An interplay with E-cadherin. PLoS One 8(11):e81579","journal-title":"PLoS One"},{"key":"9778_CR33","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.bbagen.2012.10.021","volume":"1830","author":"SS Pinho","year":"2013","unstructured":"Pinho SS, Figureiredo J, Cabral J (2013) E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. Biochim Biophys Acta 1830:2690\u20132700","journal-title":"Biochim Biophys Acta"},{"key":"9778_CR34","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0960-9822(00)80020-2","volume":"9","author":"C Cenciarelli","year":"1999","unstructured":"Cenciarelli C, Chiaur DS, Guardavaccaro D, Parks W, Vidal M et al (1999) Identification of a family of human F-box proteins. Curr Biol 9:1177\u20131179","journal-title":"Curr Biol"},{"key":"9778_CR35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc3700","volume":"14","author":"Z Wang","year":"2014","unstructured":"Wang Z, Liu P, Inuzuka H, Wei W (2014) Roles of F-box proteins in cancer. Nat Rev Cancer 14:233\u2013247","journal-title":"Nat Rev Cancer"},{"key":"9778_CR36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/genetics\/150.2.613","volume":"150","author":"MS Singer","year":"1998","unstructured":"Singer MS, Kahana A, Wolf AJ, Meisinger LL, Peterson SE et al (1998) Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. Genetics 150:613\u2013632","journal-title":"Genetics"},{"key":"9778_CR37","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0960-9822(02)00901-6","volume":"12","author":"Q Feng","year":"2002","unstructured":"Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P et al (2002) Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol 12:1052\u20131058","journal-title":"Curr Biol"},{"key":"9778_CR38","doi-asserted-by":"crossref","first-page":"30421","DOI":"10.1074\/jbc.C200366200","volume":"277","author":"N Lacoste","year":"2002","unstructured":"Lacoste N, Utley RT, Hunter JM, Poirier GG, C\u00f4te J (2002) Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase. J Biol Chem 277:30421\u201330424","journal-title":"J Biol Chem"},{"key":"9778_CR39","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","volume":"110","author":"D Mueller","year":"2007","unstructured":"Mueller D, Bach C, Zeisig D, Garcia-Cuellar MP, Monroe S et al (2007) A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 110:4445\u20134454","journal-title":"Blood"},{"key":"9778_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/hmg\/ddl444","volume":"16","author":"E Bitoun","year":"2007","unstructured":"Bitoun E, Oliver PL, Davies KE (2007) The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet 16:92\u2013106","journal-title":"Hum Mol Genet"},{"key":"9778_CR41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1101\/gad.1898410","volume":"4","author":"M Mohan","year":"2010","unstructured":"Mohan M, Herz HM, Takahashi YH, Lin C, Lai KC et al (2010) Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). Genes Dev 4:574\u2013589","journal-title":"Genes Dev"},{"key":"9778_CR42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature03114","volume":"432","author":"Y Huyen","year":"2004","unstructured":"Huyen Y, Zgheib O, Ditullio RA Jr, Gorgoulis VG, Zacharatos P et al (2004) Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432:406\u2013411","journal-title":"Nature"},{"key":"9778_CR43","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1128\/MCB.25.19.8430-8443.2005","volume":"25","author":"R Wysocki","year":"2005","unstructured":"Wysocki R, Javaheri A, Allard S, Sha F, C\u00f4t\u00e9 J et al (2005) Role of Dot1-dependent histone H3 methylation in G1 and S phase DNA damage checkpoint functions of Rad9. Mol Cell Biol 25:8430\u20138443","journal-title":"Mol Cell Biol"},{"key":"9778_CR44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","volume":"121","author":"Y Okada","year":"2005","unstructured":"Okada Y, Feng Q, Lin Y, Jiang Q, Li Y et al (2005) hDOT1L links histone methylation to leukemogenesis. Cell 121:167\u2013178 (erratum in: Cell 121:809)","journal-title":"Cell"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-015-9778-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-015-9778-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-015-9778-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T13:53:33Z","timestamp":1650981213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-015-9778-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,10]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["9778"],"URL":"https:\/\/doi.org\/10.1007\/s10689-015-9778-z","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,10]]}}}